Alpine Immune Sciences
$10.519876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$10.51
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.82 (-7.24%) As of 7:10 PM UTC today
Why Robinhood?
You can buy or sell ALPN and other stocks, options, and ETFs commission-free!
About ALPN
Alpine Immune Sciences, Inc. Common Stock, also called Alpine Immune Sciences, is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases.
CEO
Mitchell H. Gold
Employees
57
Headquarters
Seattle, Washington
Founded
2007
Market Cap
244.05M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
71.40K
High Today
$11.25
Low Today
$10.31
Open Price
$11.25
Volume
78.26K
52 Week High
$16.37
52 Week Low
$2.58
ALPN Earnings
-$0.68
-$0.45
-$0.23
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, After Hours